Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
Topical treatment of mild to moderate actinic keratosis located on the face and head with Solaraze速 is known to be a safe and efficient treatment option. However, it is unclear if an expansion of the treatment period to 6 months will increase the rate of complete responses.

Therefore the investigators will evaluate the efficacy and safety of the treatment of actinic keratosis with Solaraze速 applied twice daily to the face and head over 3 or 6 months of treatment.
Photosensitivity Disorders
DRUG: Diclofenac|DRUG: Diclofenac
Histologically controlled complete clearance of the actinic keratosis, 6 weeks after end of treatment
Topical treatment of mild to moderate actinic keratosis located on the face and head with Solaraze速 is known to be a safe and efficient treatment option. However, it is unclear if an expansion of the treatment period to 6 months will increase the rate of complete responses.

Therefore the investigators will evaluate the efficacy and safety of the treatment of actinic keratosis with Solaraze速 applied twice daily to the face and head over 3 or 6 months of treatment.